Analysts Set DocGo Inc. (NASDAQ:DCGO) Price Target at $7.75

DocGo Inc. (NASDAQ:DCGO) has earned a consensus rating of “Buy” from the five brokerages that are covering the firm, Marketbeat reports. Five equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $7.75.

DCGO has been the subject of a number of research reports. Stifel Nicolaus lowered their price target on shares of DocGo from $8.00 to $6.50 and set a “buy” rating for the company in a report on Tuesday, April 30th. Needham & Company LLC decreased their price target on DocGo from $10.00 to $7.00 and set a “buy” rating on the stock in a report on Thursday, May 9th. Canaccord Genuity Group lowered their target price on shares of DocGo from $9.00 to $5.00 and set a “buy” rating for the company in a report on Thursday, May 9th. Cantor Fitzgerald decreased their price objective on shares of DocGo from $11.00 to $5.00 and set an “overweight” rating for the company in a report on Thursday, May 9th. Finally, BTIG Research cut their price objective on DocGo from $11.00 to $7.00 and set a “buy” rating on the stock in a report on Thursday, May 9th.

DocGo Stock Performance

DocGo stock opened at $2.84 on Wednesday. The business’s fifty day moving average is $3.11 and its two-hundred day moving average is $3.58. The firm has a market cap of $288.46 million, a P/E ratio of 14.20, a P/E/G ratio of 1.46 and a beta of 0.91. DocGo has a 52 week low of $2.78 and a 52 week high of $10.82.

DocGo (NASDAQ:DCGO) last issued its quarterly earnings results on Wednesday, May 8th. The company reported $0.09 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.09. The business had revenue of $192.09 million for the quarter, compared to the consensus estimate of $185.36 million. DocGo had a net margin of 2.98% and a return on equity of 6.20%. On average, equities research analysts predict that DocGo will post 0.24 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Lee Bienstock acquired 25,000 shares of the company’s stock in a transaction dated Monday, May 13th. The shares were bought at an average price of $3.15 per share, for a total transaction of $78,750.00. Following the purchase, the chief executive officer now directly owns 1,220,845 shares in the company, valued at approximately $3,845,661.75. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other DocGo news, CEO Lee Bienstock acquired 25,000 shares of the business’s stock in a transaction dated Monday, May 13th. The stock was bought at an average cost of $3.15 per share, with a total value of $78,750.00. Following the completion of the transaction, the chief executive officer now directly owns 1,220,845 shares in the company, valued at approximately $3,845,661.75. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, General Counsel Ely D. Tendler purchased 10,000 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The stock was acquired at an average price of $3.13 per share, for a total transaction of $31,300.00. Following the purchase, the general counsel now owns 162,933 shares in the company, valued at approximately $509,980.29. The disclosure for this purchase can be found here. 2.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On DocGo

A number of institutional investors have recently made changes to their positions in DCGO. AJOVista LLC acquired a new position in DocGo in the 4th quarter valued at $25,000. Cape Investment Advisory Inc. bought a new stake in shares of DocGo in the fourth quarter valued at about $63,000. Verdence Capital Advisors LLC acquired a new position in shares of DocGo in the first quarter valued at about $64,000. Worth Venture Partners LLC increased its position in DocGo by 36.3% during the third quarter. Worth Venture Partners LLC now owns 16,028 shares of the company’s stock worth $85,000 after acquiring an additional 4,265 shares during the period. Finally, Intrust Bank NA acquired a new stake in DocGo in the 4th quarter worth about $85,000. Institutional investors own 56.44% of the company’s stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.